Prediabetic State
155
18
25
89
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Published Results
22 trials with published results (14%)
Research Maturity
89 completed trials (57% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.5%
7 terminated out of 155 trials
92.7%
+6.1% vs benchmark
14%
21 trials in Phase 3/4
25%
22 of 89 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 89 completed trials
Clinical Trials (155)
Glycemic Effect of Diazoxide in NAFLD
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Enhancing Mental and Physical Health of Women Veterans
Sleep for Health Study on the Effects of Cognitive Behavioral Therapy for Insomnia on Diabetes Risk
Presessions for the National Diabetes Prevention Program
PREDICT-DM: Community Pharmacy-Based Point-of-Care Testing for Undiagnosed T2DM
Long-term Health and Economic Effects of an Individualized Lifestyle Intervention (LI-PAD-Extended)
Use of Empagliflozin to Treat Prediabetes
Human Models of Selective Insulin Resistance: Alpelisib, Part I
The GRoceries Aimed at Increasing Nutrition Study
Comparative Effects of High-Intensity Interval Training and Continuous Endurance Training Among Prediabetic Patients
Effect of a Collagen Hydrolysate on Postprandial Blood Glucose Profile in Prediabetic and Healthy Subjects
Role of Aging and Individual Variation in Exercise Training Responsiveness
Effect of Zinc on Glucose Homeostasis
Effect of Insulin Lowering on Lipogenesis
Time-restricted Eating, Window Timing, Type 2 Diabetes Status and Sex on Glycemic Control
Effectiveness of the Brazilian Diabetes Prevention Program
Heat and Exercise in Aging as Therapy (HEAT)
AI-Driven Metabolic Cohort in Overweight/Obese Chinese Adults
Restoring 24-hour Substrate Rhythmicity to Improve Glycemic Control by Timing of Lifestyle Factors